Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HMPL-306 by Hutchison MediPharma for Myelodysplastic Syndrome: Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase...
HMPL-306 by Hutchison MediPharma for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Acute Myelocytic Leukemia (AML, Acute Myeloblastic...
HMPL-306 by Hutchison MediPharma for Myeloproliferative Disorders: Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myeloproliferative Disorders. According to GlobalData, Phase...
HMPL-306 by Hutchison MediPharma for Hematological Tumor: Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Hematological Tumor. According to GlobalData, Phase...